Research on Non-Small Cell Lung Cancer Reported by a Researcher at Institute of Tuberculosis and Lung Diseases (The Advantage of Targeted Next-Generation Sequencing over qPCR in Testing for Druggable EGFR Variants in Non-Small-Cell Lung Cancer).

Zdroj:	Cancer Weekly; 8/6/2024, p966-966, 1p
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu